Robustness Testing in Protein Assay Validation

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Robustness testing evaluates how deliberate small changes in assay conditions affect results, identifying which variables require tight control for reliable protein quantification.
Use a Plackett-Burman experimental design to screen multiple factors simultaneously, then set method control limits based on statistically significant effects.
Robustness testing does not replace full validation, and results apply only to the specific assay protocol and sample types tested.

At a Glance

Design Element	Purpose	Practical Decision
One-factor-at-a-time	Baseline comparison, simple troubleshooting	Useful for confirming a suspected variable but inefficient for screening many factors
Full factorial design	Complete interaction assessment	Best for final method characterization with few variables
Plackett-Burman design	Screen many factors with few experiments	Choose when testing 5 to 15 variables with limited sample material
Response surface methodology	Optimize and model factor interactions	Apply after screening identifies critical variables

Understanding Assay Robustness in Protein Quantification

Protein assay robustness refers to the capacity of an analytical procedure to remain unaffected by small, deliberate variations in method parameters. This characteristic provides assurance that the assay will produce reliable results during routine use, where conditions may shift slightly from the original validation environment. For researchers working with protein quantification, robustness testing answers a practical question: which variables must be tightly controlled to obtain trustworthy measurements?

The concept of robustness sits within the broader framework of analytical method validation. While accuracy, precision, and linearity describe how well an assay performs under ideal conditions, robustness describes how well it performs when conditions change. A protein assay that works perfectly in one laboratory on one day may fail when transferred to another laboratory, another instrument, or another operator. Robustness testing identifies these vulnerabilities before they cause problems.

The National Institute of Standards and Technology emphasizes that measurement science depends on understanding how variables affect results. Their laboratory programs focus on developing measurement methods that produce consistent results across different settings and operators. This principle applies directly to protein assays, where the goal is to ensure that a measured protein concentration reflects the sample instead of the specific conditions of the measurement.

For researchers using protein assays, the practical consequence of robustness testing is the establishment of control limits. These limits define the acceptable range for each method parameter, such as incubation time, temperature, or reagent concentration. When a parameter falls outside these limits, the assay results become unreliable and the measurement should be repeated under controlled conditions.

Robustness testing also serves a diagnostic function. When an assay produces unexpected results, the robustness data helps identify which parameter may have drifted outside its acceptable range. This information guides troubleshooting and prevents the common problem of repeating an assay without understanding why it failed.

Core Principles of Robustness Testing

Defining the Tested Parameters

Robustness testing begins with identifying which parameters could plausibly affect assay performance. For protein assays, these parameters typically include incubation time, incubation temperature, reagent concentration, buffer pH, sample volume, and detection wavelength. The selection of parameters depends on the specific assay format and the steps where variation is most likely to occur.

Each parameter requires a defined range for testing. This range should represent the variation that might occur during normal use, not extreme conditions. For example, if an assay specifies a 30 minute incubation at room temperature, the robustness test might evaluate 28 to 32 minutes and 20 to 25 degrees Celsius. The range should be small enough to reflect realistic variation but large enough to detect meaningful effects.

The choice of parameters and ranges should be documented in the validation protocol. This documentation serves two purposes. First, it ensures that the robustness testing is systematic and reproducible. Second, it provides a record that can be reviewed when the method is transferred to another laboratory or when problems arise.

Selecting the Experimental Design

The experimental design determines how many experiments are needed and what information they provide. The simplest approach is to vary one parameter at a time while holding all others constant. This design is easy to implement and interpret, but it requires many experiments when multiple parameters are tested. It also cannot detect interactions between parameters, where the effect of one parameter depends on the level of another.

Factorial designs test multiple parameters simultaneously. A full factorial design tests all possible combinations of the selected parameters and their levels. This design provides complete information about main effects and interactions, but the number of experiments grows rapidly with the number of parameters. A full factorial design with six parameters at two levels requires 64 experiments, which may be impractical for routine laboratory use.

The Plackett-Burman design offers a more efficient alternative for screening many parameters. This design uses a fraction of the full factorial experiments while still providing estimates of the main effects for each parameter. The design is particularly useful when the goal is to identify which parameters have the greatest effect on the assay, instead of to quantify the exact relationship between each parameter and the response.

The choice of design depends on the stage of method development and the resources available. Early in development, when many parameters might be important, a screening design such as Plackett-Burman is appropriate. Later, when the critical parameters are known, a more detailed design can be used to define the acceptable ranges.

Interpreting Robustness Results

The results of a robustness test are typically expressed as the effect of each parameter on the assay response. For a protein assay, the response is usually the measured absorbance or the calculated protein concentration. The effect of a parameter is the difference between the average response at the high level and the average response at the low level.

A parameter with a small effect relative to the assay precision is considered robust. The assay can tolerate variation in this parameter without affecting the results. A parameter with a large effect is considered critical and must be controlled within a narrow range.

The interpretation of robustness results requires a threshold for what constitutes an acceptable effect. This threshold should be based on the assay precision and the intended use of the results. For example, if the assay has a coefficient of variation of 5 percent, a parameter that changes the response by less than 5 percent might be considered acceptable. The threshold should be defined in the validation protocol before the robustness testing begins.

The results of robustness testing should be used to set method control limits. These limits define the acceptable range for each parameter in the final method. The limits should be based on the robustness data, not on the original method conditions. If a parameter shows a significant effect at the tested range, the control limit should be narrower than the tested range.

Implementing a Robustness Testing Protocol

Step 1: Define the Assay and Its Parameters

The first step in robustness testing is to define the assay protocol and identify the parameters that could affect the results. This definition should include the exact steps of the assay, the reagents and their concentrations, the incubation conditions, and the detection method. The parameters should be listed in a table with their nominal values and the range to be tested.

For a typical protein assay, the parameters might include the sample volume, the reagent volume, the incubation time, the incubation temperature, the detection wavelength, and the buffer pH. The range for each parameter should be based on the expected variation in the laboratory. For example, if the laboratory temperature varies between 20 and 25 degrees Celsius, the incubation temperature range should reflect this variation.

The definition of the assay and its parameters should be documented in the laboratory notebook or the validation protocol. This documentation provides the basis for the robustness testing and for the interpretation of the results.

Step 2: Prepare the Test Samples

The test samples for robustness testing should be representative of the samples that will be analyzed with the assay. The samples should have a known protein concentration, and the concentration should be within the range of the assay. The samples should be prepared in sufficient quantity to allow all the experiments to be performed with the same batch of sample.

The sample preparation should follow the same protocol that will be used for the actual samples. This includes the dilution steps, the buffer conditions, and any other sample preparation steps. The sample should be stable for the duration of the experiments, and the stability should be verified before the experiments begin.

The number of samples needed depends on the experimental design. For a Plackett-Burman design with six parameters, the design requires 12 experiments. Each experiment should be performed in duplicate or triplicate to provide an estimate of the assay precision. The total number of samples should be calculated before the experiment begins.

Step 3: Run the Experiments

The experiments should be run in a random order to avoid any systematic bias. The randomization ensures that any drift in the assay over time is not confounded with the parameter effects. The experiments should be performed by the same operator, using the same equipment, and on the same day if possible.

Each experiment should be performed according to the conditions specified in the design. The conditions for each experiment should be recorded, including the actual values of the parameters. The actual values may differ slightly from the target values, and these differences should be recorded.

The results of each experiment should be recorded in a table. The table should include the experiment number, the parameter values, and the response. The response should be the measured absorbance or the calculated protein concentration.

Step 4: Analyze the Results

The analysis of the robustness results involves calculating the effect of each parameter on the response. For a Plackett-Burman design, the effect of each parameter is calculated as the difference between the average response at the high level and the average response at the low level. This calculation is straightforward and can be performed in a spreadsheet.

The effects should be compared to the assay precision. The assay precision is estimated from the replicate experiments. The standard deviation of the replicates provides an estimate of the assay precision. The effect of a parameter is considered significant if it is larger than the assay precision.

The results of the analysis should be presented in a table that shows the effect of each parameter and the significance of the effect. This table provides the basis for setting the method control limits.

Step 5: Set Method Control Limits

The method control limits define the acceptable range for each parameter in the assay. The limits should be based on the robustness data. For parameters with a significant effect, the limits should be set to the range that was tested. For parameters with no significant effect, the limits can be set to a wider range.

The control limits should be documented in the method protocol. The protocol should state the acceptable range for each parameter and the action to be taken if a parameter falls outside the range. The action might be to repeat the assay, to adjust the parameter, or to reject the results.

The control limits should be reviewed periodically and updated if the assay conditions change. The review should be based on the assay performance and the results of any quality control samples.

Records and Measurements

Data to Record During Robustness Testing

The records from a robustness test should be complete enough to allow the test to be repeated and the results to be verified. The records should include the assay protocol, the parameters and their ranges, the experimental design, the actual conditions for each experiment, the measured responses, and the analysis of the results.

The records should also include the sample information, including the protein concentration and the sample preparation. The records should include the equipment information, including the instrument model and the calibration status. The records should include the operator information and the date and time of the experiments.

The records should be stored in a laboratory notebook or in an electronic laboratory information management system. The records should be retained for the period required by the laboratory or the institution.

Interpreting the Results

The interpretation of the robustness results should be based on the statistical analysis and the practical context. A parameter with a significant effect should be controlled within the tested range. A parameter with no significant effect can be allowed to vary within a wider range.

The interpretation should also consider the direction of the effect. A parameter that increases the response at the high level might require a different control strategy than a parameter that decreases the response. The direction of the effect can be used to set the control limits.

The interpretation should be documented in the validation report. The report should include the results of the robustness testing and the rationale for the control limits. The report should be reviewed by the laboratory supervisor or the quality assurance team.

Using the Results for Method Transfer

The robustness results are useful when the method is transferred to another laboratory or to another instrument. The results define the conditions that must be controlled to obtain reliable results. The receiving laboratory can use the results to set up the method and to verify that the method performs as expected.

The robustness results are also useful when the method is used for a new application. The results define the conditions that must be controlled for the new application. The results can be used to determine whether the method is suitable for the new application.

Common Failure Patterns in Robustness Testing

Failure to Define the Parameters

A common failure in robustness testing is the failure to define the parameters and their ranges before the experiment begins. This failure leads to an experiment that is not systematic and results that are difficult to interpret. The parameters should be defined in the protocol before the experiment begins.

Failure to Use a Design

Another common failure is the failure to use a design. The experiment is performed by varying one parameter at a time, which requires many experiments and cannot detect interactions. The use of a design such as Plackett-Burman allows the experiment to be performed with fewer experiments and provides more information.

Failure to Randomize the Experiments

The failure to randomize the experiments can introduce bias into the results. The experiments should be performed in a random order to avoid the effects of any drift in the assay conditions. The randomization should be performed before the experiment begins.

Failure to Record the Actual Values

The failure to record the actual values of the parameters is a common failure. The actual values may differ from the designed values, and these differences can affect the results. The actual values should be recorded for each experiment.

Failure to Analyze the Results

The failure to analyze the results is a common failure. The results should be analyzed to calculate the effect of each parameter and to determine the significance of the effect. The analysis should be performed using the appropriate statistical methods.

Welfare and Safety Context

Biosafety Considerations

Protein assay robustness testing involves the use of biological samples and reagents. The samples may contain infectious agents, and the reagents may be hazardous. The biosafety level of the laboratory should be appropriate for the samples and reagents used.

The CDC and NIH provide guidelines for biosafety in microbiological and biomedical laboratories. These guidelines describe the biosafety levels and the practices required for each level. The laboratory should follow these guidelines when working with biological samples.

The biosafety level should be determined by a risk assessment. The risk assessment should consider the nature of the samples, the procedures, and the potential for exposure. The risk assessment should be documented and reviewed.

Recombinant and Synthetic Nucleic Acid Oversight

If the protein assay involves recombinant or synthetic nucleic acid molecules, the work may be subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. These guidelines describe the oversight requirements for this work.

The guidelines require that the work be reviewed by the Institutional Biosafety Committee. The committee reviews the risk assessment and the containment level for the work. The laboratory should ensure that the work is conducted in accordance with the guidelines.

Chemical Safety

The reagents used in protein assays may be hazardous. The safety data sheets for the reagents should be reviewed before the experiment. The laboratory should use the appropriate personal protective equipment and the appropriate containment for the reagents.

The waste from the experiments should be disposed of according to the institutional and regulatory requirements. The waste should be labeled and stored appropriately.

Building a Practical Robustness Decision Framework for Protein Assays

Establishing a Tiered Response System Based on Effect Size

A robustness test produces a list of parameter effects, but the practical challenge is translating those numbers into daily laboratory decisions. A tiered response system provides a structured way to convert statistical outputs into concrete actions. This framework assigns each tested parameter to one of three tiers based on the magnitude of its effect relative to assay precision.

The first tier contains parameters with effects smaller than the assay noise. These parameters require no special control measures beyond routine laboratory practice. For example, if the detection wavelength can shift by 2 nanometers without changing the measured protein concentration beyond the assay coefficient of variation, the laboratory does not need to calibrate the spectrophotometer before every run. The second tier contains parameters with effects that exceed the assay noise but remain within a range that can be managed through simple procedural controls. These parameters require documented control limits and a check step in the routine workflow. The third tier contains parameters with effects large enough to compromise the assay if they drift. These parameters require the most stringent controls, including calibration checks, operator training, and possibly a redesign of the assay step to reduce sensitivity to the parameter.

The tier assignment should be made during the validation phase and documented in the method protocol. The assignment should be based on the robustness data, not on intuition or prior assumptions about which parameters matter. A parameter that was expected to be critical may show no effect, while a parameter that seemed minor may show a large effect. The data should drive the tier assignment.

The tiered system also provides a framework for troubleshooting. When an assay fails, the laboratory can check the tier three parameters first, then the tier two parameters, and finally the tier one parameters. This ordered approach prevents the common problem of checking parameters in the order they appear in the protocol instead of the order of their impact on the assay.

Establishing the Effect Threshold Before Data Collection

The threshold for what constitutes a significant effect must be defined before the robustness experiments begin. This threshold is the boundary between tier one and tier two parameters. The threshold should be based on the intended use of the assay results and the assay precision, not on a generic statistical cutoff.

The assay precision is estimated from the replicate measurements in the robustness experiment. The standard deviation of the replicates provides a measure of the assay noise. The threshold for a significant effect should be set relative to this noise. A common approach is to set the threshold at two times the standard deviation of the replicates. This threshold ensures that a parameter effect must be larger than the assay noise to be considered significant.

The threshold should also consider the intended use of the results. If the assay is used to determine whether a protein concentration exceeds a regulatory limit, the threshold should be tighter than if the assay is used for a relative comparison between samples. The threshold should be documented in the validation protocol before the experiments begin.

The threshold should be reviewed after the robustness data are collected. If the assay precision is better than expected, the threshold can be tightened. If the assay precision is worse than expected, the threshold may need to be relaxed. The review should be documented and the final threshold should be recorded in the method protocol.

Assigning Control Limits for Each Parameter

The control limits for each parameter should be derived from the robustness data and the tier assignment. For tier one parameters, the control limits can be set to the full range tested in the robustness experiment. For tier two parameters, the control limits should be set to the range that produced acceptable results. For tier three parameters, the control limits should be set to the narrowest range that is practical in the laboratory.

The control limits should be expressed in the same units as the parameter. For example, the control limit for incubation time should be expressed in minutes, and the control limit for temperature should be expressed in degrees Celsius. The control limits should be recorded in the method protocol and posted in the laboratory where the assay is performed.

The control limits should be verified during routine use. The laboratory should record the actual parameter values for each assay run and compare them to the control limits. If a parameter falls outside the control limits, the run should be flagged and the results should be reviewed. The review should determine whether the results are acceptable or whether the run should be repeated.

The control limits should be reviewed periodically. The review should consider the assay performance, the results of quality control samples, and any changes in the laboratory environment. The review should be documented and the control limits should be updated if necessary.

A Structured Record System for Robustness Data

The Robustness Parameter Log

A dedicated parameter log provides a structured way to record the conditions of each robustness experiment. The log should include the experiment number, the date, the operator, the parameter values, and the measured response. The log should be designed before the experiment begins and should be used consistently throughout the experiment.

The parameter log should include columns for each parameter tested. The columns should be labeled with the parameter name and the units. The log should also include a column for the measured response and a column for the calculated protein concentration. The log should include a column for the actual parameter values, which may differ from the target values.

The parameter log should be maintained in a laboratory notebook or in an electronic spreadsheet. The log should be reviewed by the laboratory supervisor or the quality assurance team after the experiment is complete. The review should verify that the log is complete and that the recorded values are consistent with the experimental design.

The parameter log serves as the primary record for the robustness experiment. The log should be retained for the period required by the laboratory or the institution. The log should be available for review during method transfer or during an audit.

The Control Limit Chart

The control limit chart is a visual tool that shows the acceptable range for each parameter. The chart should be posted in the laboratory where the assay is performed. The chart should show the parameter name, the control limits, and the tier assignment.

The control limit chart should be updated when the control limits are changed. The chart should be reviewed periodically to ensure that it reflects the current method protocol. The chart should be used by the laboratory staff to verify that the assay conditions are within the acceptable range.

The control limit chart also serves as a training tool for new operators. The chart shows which parameters require the most attention and which parameters can be allowed to vary. The chart should be included in the training materials for the assay.

The Robustness Summary Report

The robustness summary report is the final record of the robustness testing. The report should include the experimental design, the parameter effects, the tier assignments, and the control limits. The report should also include the threshold used to determine significance and the rationale for the threshold.

The report should be written in a clear and concise format. The report should be reviewed by the laboratory supervisor and the quality assurance team. The report should be retained with the validation records for the assay.

The report should be used when the method is transferred to another laboratory. The report provides the receiving laboratory with the information needed to set up the method and to verify that the method performs as expected. The report should also be used when the method is reviewed or updated.

Troubleshooting Method for Assay Failures

The Parameter Drift Check

When an assay produces unexpected results, the first step is to check whether any parameter has drifted outside its control limits. The parameter drift check should be performed using the control limit chart and the parameter log. The laboratory should compare the actual parameter values for the failed run to the control limits.

The parameter drift check should be performed in the order of the tier assignment. The tier three parameters should be checked first, then the tier two parameters, and finally the tier one parameters. This order ensures that the most critical parameters are checked first.

If a parameter has drifted outside its control limits, the laboratory should determine the cause of the drift. The cause might be an equipment malfunction, a reagent problem, or an operator error. The cause should be corrected and the assay should be repeated.

If no parameter has drifted outside its control limits, the laboratory should investigate other causes of the failure. The investigation should include a review of the sample preparation, the reagent preparation, and the instrument calibration. The investigation should be documented and the findings should be recorded.

The Interaction Check

The robustness data can also be used to check for interactions between parameters. An interaction occurs when the effect of one parameter depends on the level of another parameter. The interaction check should be performed when the assay produces unexpected results and the parameter drift check does not identify a cause.

The interaction check should be based on the robustness data. The data should be analyzed to determine whether the effect of one parameter changes when another parameter is at a different level. The analysis should be performed using the appropriate statistical methods.

If an interaction is identified, the laboratory should determine the conditions under which the interaction occurs. The laboratory should then adjust the control limits to avoid the interaction. The adjustment should be documented and the method protocol should be updated.

The Escalation Protocol

The escalation protocol defines the steps to be taken when the troubleshooting does not resolve the problem. The protocol should be documented in the method protocol and should be followed by the laboratory staff.

The first step in the escalation protocol is to repeat the assay with a fresh sample and fresh reagents. The repeat should be performed under the control conditions. If the repeat produces acceptable results, the original failure was likely due to a transient problem.

The second step is to review the robustness data and the control limits. The review should determine whether the control limits are appropriate for the current assay conditions. If the control limits are too tight or too loose, they should be adjusted.

The third step is to contact the laboratory supervisor or the quality assurance team. The supervisor should review the failure and the troubleshooting steps. The supervisor should determine whether the method needs to be revalidated or whether the failure is due to a specific cause.

The escalation protocol should be documented and the results of the escalation should be recorded. The record should include the failure, the troubleshooting steps, and the resolution.

Comparison of Robustness Testing Approaches

The Screening Approach

The screening approach uses a Plackett-Burman design to identify the parameters that have the greatest effect on the assay. The screening approach is efficient and requires fewer experiments than a full factorial design. The screening approach is appropriate when many parameters are tested and the goal is to identify the critical parameters.

The screening approach provides estimates of the main effects for each parameter. The screening approach does not provide information about interactions between parameters. The screening approach is appropriate for the initial robustness testing, when the goal is to identify the parameters that require tight control.

The screening approach should be followed by a more detailed design for the critical parameters. The detailed design should be used to define the control limits for the critical parameters. The detailed design should also be used to check for interactions between the critical parameters.

The Factorial Approach

The factorial approach uses a full factorial design to test all possible combinations of the selected parameters. The factorial approach provides complete information about the main effects and the interactions between the parameters. The factorial approach is appropriate when the number of parameters is small and the interactions are important.

The factorial approach requires more experiments than the screening approach. The factorial approach is appropriate for the final characterization of the method, when the critical parameters are known and the interactions need to be quantified.

The factorial approach should be used when the method is being finalized and the control limits are being set. The factorial approach provides the information needed to set the control limits and to determine the acceptable range for each parameter.

The Sequential Approach

The sequential approach combines the screening and the factorial approaches. The sequential approach begins with a screening design to identify the critical parameters. The sequential approach then uses a factorial design to characterize the critical parameters and to determine the interactions.

The sequential approach is the most efficient approach for robustness testing. The sequential approach uses the screening design to reduce the number of parameters, and then uses the factorial design to characterize the critical parameters. The sequential approach is appropriate for most protein assays.

The sequential approach should be documented in the validation protocol. The results of the screening design should be recorded, and the results of the factorial design should be recorded. The results should be used to set the control limits and to define the method protocol.

Records and Measurements

Data to Record During Robustness Testing

Interpreting the Results

Using the Results for Method Transfer

Common Failure Patterns in Robustness Testing

Failure to Define the Parameters

Failure to Use a Design

Failure to Randomize the Experiments

Failure to Record the Actual Values

Failure to Analyze the Results

Welfare and Safety Context

Biosafety Considerations

Recombinant and Synthetic Nucleic Acid Oversight

Chemical Safety

The waste from the experiments should be disposed of according to the institutional and regulatory requirements. The waste should be labeled and stored appropriately.

Frequently Asked Questions

What is the difference between robustness and ruggedness in protein assay validation?

Robustness refers to the ability of an assay to remain unaffected by small, deliberate variations in method parameters within a single laboratory. Ruggedness refers to the ability of an assay to produce the same results when performed in different laboratories, by different operators, or on different instruments. Both are important for method validation, but they address different sources of variation.

How many parameters should be tested in a robustness study?

The number of parameters should be based on the assay protocol and the potential sources of variation. A typical robustness study tests 5 to 10 parameters. The parameters should be selected based on the assay protocol and the experience of the laboratory.

What is the difference between a screening design and a full factorial design?

A screening design such as Plackett-Burman is used to identify the parameters that have the greatest effect on the assay. A full factorial design is used to quantify the effects of the parameters and their interactions. The screening design is more efficient, but it provides less information.

How do I choose the range for each parameter in a robustness test?

The range should represent the small variation that might occur in practice. The range should be based on the typical variation in the laboratory, such as the variation in temperature or the variation in reagent preparation. The range should be small enough to be realistic but large enough to detect meaningful effects.

What is the difference between a robustness test and a system suitability test?

A robustness test is performed during method validation to determine the effect of parameter variations. A system suitability test is performed before each run to verify that the system is working properly. The system suitability test is a check of the system, while the robustness test is a check of the method.

How do I interpret the results of a robustness test?

The results are interpreted by comparing the effect of each parameter to the assay precision. A parameter with an effect greater than the assay precision is considered significant. The significant parameters should be controlled within the tested range.

What should I do if a parameter shows a significant effect in the robustness test?

If a parameter shows a significant effect, the method should be modified to reduce the effect. The modification might be to change the parameter range, to change the assay conditions, or to add a control step. The modified method should be revalidated.

How often should robustness testing be repeated?

Robustness testing should be repeated when the method is changed, when the method is transferred to another laboratory, or when the method is used for a new application. The testing should also be repeated if the assay performance changes.

Using the Evidence

Source	Best use in this topic	Important limitation
Molecular Biology and Laboratory Methods	official guidance	Check the linked page for current local requirements
Biosafety in Microbiological and Biomedical Laboratories	official guidance	Check the linked page for current local requirements
NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules	official guidance	Check the linked page for current local requirements

Related Molecular Biology Guides

References and Further Reading

Molecular Biology and Laboratory Methods. National Library of Medicine.
Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
Addgene Protocols. Addgene.
MIQE Guidelines. Clinical Chemistry.
NIST Laboratory Programs. National Institute of Standards and Technology.
Why C-reactive protein is one of the most requested tests in clinical laboratories?. Clinical chemistry and laboratory medicine, 2023.
Lyme neuroborreliosis.. Current opinion in infectious diseases, 2019.
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.. Emerging microbes & infections, 2020.
CeLINC, a fluorescence-based protein-protein interaction assay in Caenorhabditis elegans.. Genetics, 2021.
Neurovirulence.. Developments in biological standardization, 1999.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.